Answers are grounded in this paper and cite their sources.
Reveals that Sca1+ endothelial cells act as reserve progenitors that expand after vascular and cardiac injury in mice, highlighting a functional hierarchy in tissue regeneration.
Vascular endothelial cell renewal, repair and regeneration are critical for tissue homeostasis and response to injuries 1 . Unraveling the heterogeneity and hierarchy of endothelial cells in homeostasis and after injuries provides valuable information of potential targets for therapeutic neovascularization. Stem cell antigen-1 (Sca1) is a member of the ly-6 family, which was reported as cell surface markers of hematopoietic stem cells 2 . Sca1 + progenitor cells residing in the heart do not contribute to cardiomyocytes, but instead adopt vascular endothelial cell fate 3 , 4 , 5 . Whether Sca1-expressing cells represent a unique population of endothelial cells (ECs) that differs from other Sca1 – ECs remains largely unknown. In addition, whether the Sca1 expression heterogeneity in ECs may indicate the existence of a functional hierarchy for endothelial cells in angiogenesis is unclear. We first isolated CD31 + endothelial cells by FACS and performed single-cell RNA sequencing (scRNA-seq). Uniform manifold approximation and projection (UMAP) analysis of this dataset revealed clusters of endothelial and adventitial cell populations based on marker gene expression (Supplementary Fig. S 1a, b ), with Ly6a (Sca1) marking different populations of ECs and makers for others subtype cells such as pericytes, endocardial cells and fibroblasts (Supplementary Fig. S 1b, c ). Further pathway enrichment analysis showed that cell proliferation and angiogenesis-related pathways were highly enriched in Sca1 high ECs compared with the Sca1 low ECs (Supplementary Fig. S 1d ), indicating these Sca1 high ECs may exhibit specific functions during cardiac homeostasis and after injuries. Next we generated Sca1-2A-CreER;R26-GFP 6 to lineage trace Sca1 + cells in the adult tissues during homeostasis and after injury (Fig. 1a ). We collected heart samples at 24–48 hours after tamoxifen induction (Fig. 1b ). Immunostaining for GFP, VE-Cad or PECAM showed that 30.54 ± 1.01% of VE-Cad + and 31.90 ± 0.67% of PECAM + ECs express GFP (Fig. 1c, d ). We confirmed that ~30% of ECs were GFP + by FACS analysis of heart ventricles (Fig. 1e ). We next examined the heart tissues at 12 to 16 weeks after tamoxifen treatment (Fig. 1f ). By immunostaining and FACS analysis of heart ventricles, we did not find a significant increase of GFP percentage in ECs after 12–16 weeks’ tracing (Fig. 1g–i ). EdU incorporation assays showed there was no significant difference of the percentage of EdU + ECs between GFP – and GFP + EC populations (Fig. 1j ). These data indicate that Sca1 + ECs proliferate at the similar rate as Sca1 – ECs at homeostasis. Fig. 1: Sca1 + endothelial cells expand preferentially after injuries. a Schematic figure showing genetic lineage tracing of Sca1 + cells. b Schematic figure showing experimental design. c Immunostaining for GFP, VE-Cad, SM22, or PECAM on heart sections. d Quantification of the percentage of VE-Cad + or PECAM + endothelial cells (ECs) expressing GFP. e Flow cytometric analysis of CD31 + ECs expressing GFP. f Schematic diagram showing experimental design for homeostasis study. g Immunostaining for GFP, VE-Cad, SM22, or PECAM on heart sections. h Quantification of the percentage of VE-Cad + or PECAM + ECs expressing GFP. i Flow cytometric analysis and quantification of the percentage of CD31 + cells expressing GFP. j Immunostaining for EdU, GFP, and VE-Cad on heart sections. Quantification of the percentage of EdU + cells in GFP + or GFP – populations. k Schematic diagram showing experimental design for TAC study. l Sirius red staining on sections from sham and TAC hearts. m Immunostaining for GFP, VE-Cad, SM22, or PECAM on heart sections, and the quantification of the percentage of VE-Cad + or PECAM + ECs expressing GFP. n Flow cytometric analysis and quantification of the percentage CD31 + ECs expressing GFP. o Immunostaining for EdU, GFP, and VE-Cad on TAC heart sections. Quantification of the percentage of GFP – or GFP + ECs incorporating EdU. p Immunostaining for TUNEL, GFP and VE-Cad on TAC heart sections. Quantification of the percentage of GFP – or GFP + ECs that are TUNEL + . q Schematic diagram showing experimental design for wire-induced injury. r HE staining on artery sections from sham or wire injury groups. s Immunostaining for GFP and VE-Cad on sections. Quantification of the percentage of ECs expressing GFP. t Flow cytometric analysis and quantification of the percentage of CD31 + ECs expressing GFP. u Immunostaining for EdU, GFP, and VE-Cad on injury arteries. Quantification of the percentage of GFP – or GFP + ECs incorporating EdU. v Immunostaining for TUNEL, GFP, and VE-Cad on injury arteries. Quantification of the percentage of GFP – or GFP + ECs that are TUNEL + . w Cartoon image showing preferential expansion of Sca1 + ECs after TAC or wire induced artery injuries. Scale bars, 100 µm. Data are means ± SEM; n = 5; * P < 0.05; ns, non-significant. Each figure is representative of 5 individual biological samples. Full size image
No takes yet. Share an insight, caveat, or question.
Tang et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: